This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Astrazeneca Aktiebolag, Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2014.
Company Filing History:
1 out of 6 
1 out of 140 Years Active: 2014
Title: Wataru Katoda: Innovator in Adenine Compound Preparation
Introduction
Wataru Katoda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the preparation of adenine compounds. His innovative methods have implications in various scientific applications.
Latest Patents
Wataru Katoda holds a patent for a method for preparing adenine compounds. This method involves producing adenine compounds where m and n are independently integers ranging from 2 to 5. The process includes reacting specific compounds in the presence of a boron-containing reducing agent. This innovative approach enhances the efficiency of adenine compound production.
Career Highlights
Throughout his career, Wataru Katoda has worked with prominent companies such as AstraZeneca Aktiebolag and Dainippon Sumitomo Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical chemistry.
Collaborations
Wataru has collaborated with esteemed colleagues, including Kazuki Hashimoto and Kazuhiko Takahashi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Wataru Katoda's contributions to the field of adenine compound preparation highlight his role as an influential inventor. His work continues to impact the scientific community positively.